HAWRYLUK P. KENT (President & CEO) sold 0.1% of their position (607.00 shares) of MBX BIOSCIENCES, INC. on the open market
Open‑market sale worth $17.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/8/2026ACC: 0001193125-26-214574
DirectorOfficer· President & CEO
Since Feb 2026
-607.00
Net shares
Net seller
$17.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
607.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−607.00
Price / share
$29.54
Trade value
$17.93K
% of position
0.1%
5/6/2026
728.27K→727.67K
Total
Net shares
−607.00
Net value
-$17.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/6/2026 | S · Sale | −607.00 | $29.54 | $17.93K | 0.1% | 728.27K | 727.67K |
| Total | −607.00 | -$17.93K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned486.78K
Total
486.78K indirect486.78K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 486.78K | Indirect |
| Total | 486.78K | 486.78K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported